This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Chiesi Farmaceutici S.p.a., The Medicines Company. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2022
Title: Innovations by Lisa Ruderman Chen
Introduction
Lisa Ruderman Chen is a prominent inventor based in Rye, NY, known for her significant contributions to the field of medicine. With a total of eight patents to her name, she has made remarkable advancements, particularly in antiplatelet therapy.
Latest Patents
One of her latest patents focuses on the maintenance of platelet inhibition during antiplatelet therapy. This method involves administering cangrelor prior to an invasive procedure to reduce or maintain platelet inhibition in patients. This invention is particularly beneficial for patients in need of antiplatelet therapy or those at risk of thrombosis. Furthermore, it can be utilized in patients who have previously been treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.
Career Highlights
Throughout her career, Lisa has worked with notable companies such as Chiesi Farmaceutici S.p.a. and The Medicines Company. Her work in these organizations has contributed to her expertise and innovation in the medical field.
Collaborations
Some of her coworkers include Simona Skerjanec and Dawn Bell, who have collaborated with her on various projects.
Conclusion
Lisa Ruderman Chen's innovative work in antiplatelet therapy showcases her dedication to improving patient care and advancing medical science. Her contributions continue to have a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile